Skip to content

Ketamine: all studies

Page 418 of 449: studies 4,171 to 4,180 of 4,486, newest first. Back to the ketamine overview

Research

Focus on Adolescent Use of Club Drugs and "Other" Substances.

Pediatric Clinics of North America December 1, 2019 Janet F Williams, Leslie H. Lundahl 22 citations

Club drugs and "other" abusable substances are briefly overviewed as a reminder about the wide variety of known and unknown substances used by adolescents, the high potential for direct and interactive substance use effects to manifest acutely and chronically, and the vigilance needed to anticipate and recognize the new effects and drug-drug interactions arising as novel substances continue to...

DOI: 10.1016/j.pcl.2019.08.013 (opens in new tab) Full text (opens in new tab) Adolescents Club drugs Designer drugs Hallucinogens +14

Evidence that alpha blocking is due to increases in system-level oscillatory damping not neuronal population desynchronisation

Neuroimage November 29, 2019 David T. J. Liley, Suresh Muthukumaraswamy 18 citations

The attenuation of the alpha rhythm following eyes-opening (alpha blocking) is among the most robust features of the human electroencephalogram with the prevailing view being that it is caused by changes in neuronal population synchrony. To further study the basis for this phenomenon we use theoretically motivated fixed-order Auto-Regressive Moving-Average (ARMA) time series modelling to study...

DOI: 10.1016/j.neuroimage.2019.116408 (opens in new tab) Glutamatergic Population Alpha finance Nmda receptor +5

Ketamin: Einsatz bei chronischen Schmerzen und Depression

Wiener Medizinische Wochenschrift November 1, 2019 Wolfgang Jaksch, Rudolf Likar, Martin Aigner 4 citations

ZusammenfassungObwohl Ketamin seit langem bekannt und im klinischen Einsatz ist, bleiben nach wie vor Fragen rund um die vielfältigen möglichen Anwendungsfelder als Anästhetikum und Analgetikum offen. Diese betreffen nicht das klassische Einsatzgebiet in der Notfallmedizin und Anästhesie, sondern auch potentielle, neue Indikationen, in denen Ketamin in niedrigen, subanästhetischen Dosierungen...

Hallucinogens and Their Therapeutic Use: A Literature Review.

Journal of Psychiatric Practice September 1, 2019 Matthew J Begola, Jason E Schillerstrom 20 citations

The exploration of possible therapeutic benefits of hallucinogenic substances has undergone a revitalization in the past decade. This literature review investigated the published literature regarding the psychotherapeutic uses of hallucinogens in psychiatric disorders. The results showed that a variety of substances have been evaluated in the treatment of psychiatric disorders, including...

DOI: 10.1097/pra.0000000000000409 (opens in new tab) Full text (opens in new tab) Psychedelics Hallucinogens Entheogens Psychedelic drugs +12

General Anesthesia: A Probe to Explore Consciousness

Frontiers in Systems Neuroscience August 14, 2019 Vincent Bonhomme, Cécile Staquet, Javier Montupil et al. 109 citations

General anesthesia reversibly alters consciousness, without shutting down the brain globally. Depending on the anesthetic agent and dose, it may produce different consciousness states including a complete absence of subjective experience (unconsciousness), a conscious experience without perception of the environment (disconnected consciousness, like during dreaming), or episodes of oriented...

DOI: 10.3389/fnsys.2019.00036 (opens in new tab) Unconsciousness Level of consciousness Anesthetic Altered state +5

Semiology and Mechanisms of Near-Death Experiences

Current Neurology and Neuroscience Reports July 27, 2019 Costanza Peinkhofer, Jens P Dreier, Daniel Kondziella 45 citations

Purpose of reviewNear-death experiences (NDEs) are conscious perceptual experiences, including self-related emotional, spiritual, and mystical experiences, occurring in close encounters with death or in non-life-threatening situations. The origin of NDEs remains unknown. Here, we review recent advances in the understanding of NDE semiology and pathophysiology.Recent findingsRecent prospective...

Translating Molecular and Neuroendocrine Findings in PTSD and Resilience to Novel Therapies

Biological Psychiatry July 24, 2019 J. DePierro, Lauren Lepow, Adriana Feder et al.

Many biological systems are altered in association with Posttraumatic Stress Disorder (PTSD) and resilience. However, there are only few approved pharmacological treatments for PTSD, and no approved medications to enhance resilience. This paper provides a critical review of select neurobiological findings in PTSD and resilience, and also of pharmacologic approaches that have emerged from this...

New/emerging psychoactive substances and associated psychopathological consequences

Psychological Medicine July 22, 2019 Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini et al. 118 citations

BACKGROUND: The present paper provides an updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification of those NPS being commented in specialised online sources and the related short-/long-term psychopathological and medical ill-health effects. METHODS: NPS have been...

DOI: 10.1017/s0033291719001727 (opens in new tab) Psychopathology Medical prescription Synthetic cannabinoids Mental health +2

TrkB neurotrophin receptor at the core of antidepressant effects, but how?

Cell and tissue research July 1, 2019 Tomi Rantamäki

The role of brain-derived neurotrophic factor (BDNF) and its receptor TrkB has been studied in the context of mood disorders and their treatments for a couple of decades. Pharmacologically diverse antidepressant drugs increase the synthesis of BDNF in the cortex (and some subcortical structures) and this effect accounts for their ability to facilitate neurotrophic processes eventually leading...

DOI: 10.1007/s00441-018-02985-6 (opens in new tab) Full text (opens in new tab) Anesthesia Antidepressant Electroconvulsive therapy Nitrous oxide +1

Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.

Neuroimage June 24, 2019 Carla Pallavicini, Martina G. Vilas, Mirta Villarreal et al. 66 citations

Classic serotonergic psychedelics are remarkable for their capacity to induce reversible alterations in consciousness of the self and the surroundings, mediated by agonism at serotonin 5-HT2A receptors. The subjective effects elicited by dissociative drugs acting as N-methyl-D-aspartate (NMDA) antagonists (e.g. ketamine and phencyclidine) overlap in certain domains with those of serotonergic...

DOI: 10.1016/j.neuroimage.2019.06.053 (opens in new tab) Brain activity Brainwaves Neural activity Electrical activity +23